Navigation Links
Genesis Biosciences Announces New Hire and Promotions on Operational and Scientific Staff
Date:9/21/2011

LAWRENCEVILLE, Ga. and CARDIFF, Wales, Sept. 21, 2011 /PRNewswire/ -- Genesis Biosciences, a global leader in custom fermentation, microbial product formulation and antimicrobial product development, announced today that Casey Smallwood has been promoted to vice president of operations. Additionally, Mauricio Amaya and Amit Choksi have been promoted to laboratory manager and fermentation manager, respectively, and Prasanth Maddipati joins Genesis as a new fermentation scientist. These team members will be located in Genesis' newly renovated U.S. fermentation and manufacturing facility in Lawrenceville, GA.

(Logo:  http://photos.prnewswire.com/prnh/20110615/MM20879LOGO)

"Casey, Mauricio, Amit and Prasanth bring valuable experience and knowledge to the Genesis operational and technical teams, and we will look to them as we continue to develop high-quality, environmentally preferred chemical, fermentation and microbial-based solutions for our customers," stated Conrad Mielcuszny, president and chief executive officer of Genesis Biosciences.

Casey Smallwood, Vice President of Operations

Casey Smallwood brings to Genesis more than 20 years of chemical development and production management  experience in the household and institutional as well as janitorial and sanitation arenas. In his role as vice president of operations, Smallwood will oversee all manufacturing and production, customer service, telesales and equipment engineering/maintenance at Genesis. Smallwood joined Genesis Biosciences (formerly Genesis Technologies) in 2000, and he has held the positions of operations manager, production manager and customer service manager. Prior to joining Genesis, Smallwood served as operations manager at Harvard Chemical Research, a chemical manufacturer of institutional and household compounds specializing in carpet care and the primary chemical manufacturer f
'/>"/>

SOURCE Genesis Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Regenesis Biomedical Announces Additions to Board of Directors
2. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
3. Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol
4. ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
5. ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
6. ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008
7. Genesis Pharmaceuticals Launches New Corporate Website
8. ThermoGenesis Presentation at Rodman & Renshaw Conference
9. Cardiogenesis Reports Third Quarter 2008 Results
10. Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System
11. Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015   Synageva BioPharma Corp. (NASDAQ: ... therapeutic products for rare disorders, today reported 2014 ... other key objectives, and financial guidance.  Synageva,s management ... 4:30 p.m. EST to review the financial results ... in today,s call by telephone, please dial (877) ...
(Date:2/26/2015)... 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... order denying motions for judgment notwithstanding the verdict, a ...
(Date:2/26/2015)... IL (PRWEB) February 26, 2015 Already ... its gauging line by expanding its Length Gauge offerings ... ACANTO gauges. , Specifically, HEIDENHAIN’s pencil probe-style ... improved force specification. Two new 1Vpp, 12mm stroke ... lower force applications. One is a variant with a ...
(Date:2/26/2015)... IL (PRWEB) February 26, 2015 Regis ... for the development of oncology drug substances. , Regis ... up of their new Potent Compound Suite (PCS) for ... a 36,000 square foot, cGMP facility in Morton Grove, ... cGMP manufacturing of potent compounds up to about one ...
Breaking Biology Technology:Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2Regis Extends cGMP Services to Oncology Market 2
... Rhythm announced today the results of a Phase 1b ... for the treatment of diabetic gastroparesis. The trial demonstrated ... diabetic gastroparesis. The findings were presented at the Digestive ... The Phase 1b clinical trial was a randomized, double-blind, ...
... To become better healers, tissue engineering need a timely and ... already are or can become the tissue they need to ... that the stiffness, viscosity, and other mechanical properties of adult ... predict whether they will turn into bone, cartilage, or fat. ...
... New York, May 21, 2012 Elsevier,s Computers & ... on 3D Object Retrieval which will incorporate the Collage Authoring ... place winner of the 2011 Executable Paper Grand Challenge. The ... Eurographics 2012 on May 13, during the 3DOR Workshop. ...
Cached Biology Technology:Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Diabetic Gastroparesis 2Physical properties predict stem cell outcome 2Physical properties predict stem cell outcome 3
(Date:2/5/2015)...   Epic Sciences , a precision diagnostics company dedicated ... Murali Prahalad , Ph.D., president and CEO, is scheduled to ... 2015: Silicon Valley, which is taking place at the Computer ... on January 26-28, 2015. Dr. Prahalad will ... Last year, Epic Sciences was a finalist in the PMWC,s ...
(Date:2/5/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces it ... Conference on January 29 th at 10:30 a.m. ... of NXT-ID will present and host a live Q&A ... and its full suite of biometric technologies. Investors can ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to ... biometrics technology is to ensure that an individual is who ... technology may make use of a person,s unique physical characteristics, ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... to botulinum neurotoxins, which are among the most potent ... a bacterium found in soil and food. In the ... with nerve transmission and disrupting the communication between the ... botulinum toxins leads to an often-fatal paralysis, which is ...
... that transplanting human stem cells into spinal cords of ... start of nerve cell damage typical of the disease ... into nerve cells that make substantial connections with existing ... also known as amyotrophic lateral sclerosis (ALS). The study ...
... Researchers at the University of Pennsylvania School of Medicine ... leukemia (AML). Several lines of evidence point to a ... took over the starship Enterprise in the original Star ... , "Tribbles had never been directly linked ...
Cached Biology News:Human stem cells delay start of Lou Gehrig's disease in rats 2Human stem cells delay start of Lou Gehrig's disease in rats 3'Tribbles' protein implicated in common and aggressive form of leukemia 2
... from E. coli is a ... also contains both 5'--3'and 3'--5' ... activity enables the enzyme to ... the DNA as starting points ...
DNase I (Deoxyribonuclease I) digests single- and double-stranded DNA to oligodeoxyribonucleotides. Ribonuclease activity has been reduced to non-detectable levels....
... thymus Description: Topoisomerase I relaxes both ... breakage and rejoining of phosphodiester bonds (1,2) . ... to be differentiated by a single nucleotide pair ... active in the absence of Mn 2+ ...
...
Biology Products: